BlackRock, Inc. 13D and 13G filings for Pacira BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-19 2:40 pm Purchase |
2023-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
8,113,714 17.500% |
862,806 (+11.90%) |
Filing |
| 2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
7,250,908 15.800% |
429,390 (+6.29%) |
Filing |
| 2022-01-27 5:13 pm Unchanged |
2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
6,821,518 15.300% |
0 (Unchanged) |
Filing |
| 2022-01-26 09:16 am Sale |
2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
6,821,518 15.300% |
-278,329 (-3.92%) |
Filing |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
BLACKROCK INC BLK |
7,099,847 16.300% |
95,348 (+1.36%) |
Filing |